Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C Kain

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2003
Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malariaKevin C Kain
Journal of Travel Medicine|May 10, 2003
Atovaquone/proguanil: the need for family protectionKevin C Kain
Journal of Travel Medicine|December 13, 2018
Single-dose radical cure for Plasmodium vivaxKevin C Kain
Infection and Immunity|January 25, 2005
Peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists have minimal effects on the interaction of endothelial cells with Plasmodium falciparum-infected erythrocytesLena Serghides, Kevin C Kain
Lancet (London, England)|April 30, 2002
Mechanism of protection induced by vitamin A in falciparum malariaLena Serghides, Kevin C Kain
Journal of Travel Medicine|May 17, 2019
Fever in returning travellers and migrants: disease severity markers to improve triage and managementMichelle Ngai, Kevin C Kain
Expert Review of Anti-Infective Therapy|June 6, 2007
Advances in malaria diagnosisMichael Hawkes, Kevin C Kain
Virulence|November 29, 2019
New insights into microvascular injury to inform enhanced diagnostics and therapeutics for severe malariaClara Erice, Kevin C Kain
Expert Opinion on Investigational Drugs|April 28, 2007
Tafenoquine: a promising new antimalarial agentMaryanne Crockett, Kevin C Kain
The Journal of Infectious Diseases|June 15, 2004
Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cycle intermediates derived from delta-aminolevulinic acidTodd G Smith, Kevin C Kain
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2003
Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malariaKevin C Kain
Journal of Travel Medicine|May 10, 2003
Atovaquone/proguanil: the need for family protectionKevin C Kain
Journal of Travel Medicine|December 13, 2018
Single-dose radical cure for Plasmodium vivaxKevin C Kain
Infection and Immunity|January 25, 2005
Peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists have minimal effects on the interaction of endothelial cells with Plasmodium falciparum-infected erythrocytesLena Serghides, Kevin C Kain
Lancet (London, England)|April 30, 2002
Mechanism of protection induced by vitamin A in falciparum malariaLena Serghides, Kevin C Kain
Journal of Travel Medicine|May 17, 2019
Fever in returning travellers and migrants: disease severity markers to improve triage and managementMichelle Ngai, Kevin C Kain
Expert Review of Anti-Infective Therapy|June 6, 2007
Advances in malaria diagnosisMichael Hawkes, Kevin C Kain
Virulence|November 29, 2019
New insights into microvascular injury to inform enhanced diagnostics and therapeutics for severe malariaClara Erice, Kevin C Kain
Expert Opinion on Investigational Drugs|April 28, 2007
Tafenoquine: a promising new antimalarial agentMaryanne Crockett, Kevin C Kain
The Journal of Infectious Diseases|June 15, 2004
Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cycle intermediates derived from delta-aminolevulinic acidTodd G Smith, Kevin C Kain
Pageof 29